Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR)

Rociletinib (CO-1686), a 2,4-diaminopyrimidine derivative, is a highly potent tyrosine kinase inhibitor (TKI) that acts on epidermal growth factor receptor (EGFR) with L858R/T790M mutations. We supposed radioiodinated CO-1686 would function as a useful tool for monitoring EGFR L858R/T790M mutations....

Descripción completa

Detalles Bibliográficos
Autores principales: Fawwaz, Muammar, Mishiro, Kenji, Nishii, Ryuichi, Sawazaki, Izumi, Shiba, Kazuhiro, Kinuya, Seigo, Ogawa, Kazuma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356761/
https://www.ncbi.nlm.nih.gov/pubmed/32599930
http://dx.doi.org/10.3390/molecules25122914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356761/
https://www.ncbi.nlm.nih.gov/pubmed/32599930
http://dx.doi.org/10.3390/molecules25122914

Ejemplares similares